These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer. Fluiter K; Mook OR; Vreijling J; Langkjaer N; Højland T; Wengel J; Baas F Mol Biosyst; 2009 Aug; 5(8):838-43. PubMed ID: 19603119 [TBL] [Abstract][Full Text] [Related]
3. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development. Orum H; Wengel J Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347 [TBL] [Abstract][Full Text] [Related]
4. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide. Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430 [TBL] [Abstract][Full Text] [Related]
9. Free-radical ring closure to conformationally locked α-L-carba-LNAs and synthesis of their oligos: nuclease stability, target RNA specificity, and elicitation of RNase H. Li Q; Yuan F; Zhou C; Plashkevych O; Chattopadhyaya J J Org Chem; 2010 Sep; 75(18):6122-40. PubMed ID: 20738147 [TBL] [Abstract][Full Text] [Related]
10. Oral delivery of siRNA and antisense oligonucleotides. Akhtar S J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907 [TBL] [Abstract][Full Text] [Related]
11. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology. Möhrle BP; Kumpf M; Gauglitz G Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662 [TBL] [Abstract][Full Text] [Related]
12. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Lu PY; Xie FY; Woodle MC Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431 [TBL] [Abstract][Full Text] [Related]
13. Fine tuning of electrostatics around the internucleotidic phosphate through incorporation of modified 2',4'-carbocyclic-LNAs and -ENAs leads to significant modulation of antisense properties. Zhou C; Liu Y; Andaloussi M; Badgujar N; Plashkevych O; Chattopadhyaya J J Org Chem; 2009 Jan; 74(1):118-34. PubMed ID: 19055352 [TBL] [Abstract][Full Text] [Related]
14. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides. Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380 [TBL] [Abstract][Full Text] [Related]
16. Syntheses and base-pairing properties of locked nucleic acid nucleotides containing hypoxanthine, 2,6-diaminopurine, and 2-aminopurine nucleobases. Koshkin AA J Org Chem; 2004 May; 69(11):3711-8. PubMed ID: 15153000 [TBL] [Abstract][Full Text] [Related]
17. The application of locked nucleic acids in the treatment of cancer. Frieden M; Orum H IDrugs; 2006 Oct; 9(10):706-11. PubMed ID: 17016778 [TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity of high affinity gapmer antisense oligonucleotides is mediated by RNase H1 dependent promiscuous reduction of very long pre-mRNA transcripts. Burel SA; Hart CE; Cauntay P; Hsiao J; Machemer T; Katz M; Watt A; Bui HH; Younis H; Sabripour M; Freier SM; Hung G; Dan A; Prakash TP; Seth PP; Swayze EE; Bennett CF; Crooke ST; Henry SP Nucleic Acids Res; 2016 Mar; 44(5):2093-109. PubMed ID: 26553810 [TBL] [Abstract][Full Text] [Related]
19. NMR studies of fully modified locked nucleic acid (LNA) hybrids: solution structure of an LNA:RNA hybrid and characterization of an LNA:DNA hybrid. Nielsen KE; Rasmussen J; Kumar R; Wengel J; Jacobsen JP; Petersen M Bioconjug Chem; 2004; 15(3):449-57. PubMed ID: 15149171 [TBL] [Abstract][Full Text] [Related]
20. An LNA-based loss-of-function assay for micro-RNAs. Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]